AstraZeneca plc Company Profile (LON:AZN)

About AstraZeneca plc (LON:AZN)

AstraZeneca plc logoAstraZeneca PLC (AstraZeneca) is a biopharmaceutical company. The Company focuses on discovery and development of products, which are then manufactured, marketed and sold. The Company focuses on three main therapy areas: Oncology, Cardiovascular & Metabolic Disease (CVMD) and Respiratory, while selectively pursuing therapies in Autoimmunity, Infection and Neuroscience. In CVMD, it is expanding its portfolio into the cardiovascular-renal area with late-stage assets, such as ZS-9 and roxadustat, as well as investing to explore the benefits of its SGLT2 and GLP-1 franchises in chronic kidney disease (CKD) and heart failure (HF). The Company has approximately 40 projects in Phase I, including 29 new molecular entities (NMEs), and 11 oncology combination projects. It has approximately 40 projects in Phase II, including 25 NMEs; four significant additional indications for projects that have reached phase II, and seven oncology combination projects.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Pharmaceuticals
  • Sub-Industry: N/A
  • Symbol: LON:AZN
  • CUSIP: N/A
  • Web: www.astrazeneca.com/
Capitalization:
  • Market Cap: £65.4 billion
  • Outstanding Shares: 1,266,000,000
Average Prices:
  • 50 Day Moving Avg: GBX 4,859.28
  • 200 Day Moving Avg: GBX 4,907.26
  • 52 Week Range: GBX 3,996 - GBX 5,520
P/E:
  • Trailing P/E Ratio: 16.94
  • P/E Growth: 4.83
Sales & Book Value:
  • Annual Revenue: £21.74 billion
  • Price / Sales: 3.01
  • Book Value: GBX 10.78 per share
  • Price / Book: 4.79
Dividend:
  • Dividend Yield: 4.5%
Profitability:
  • EBITDA: £5.91 billion
  • Net Margins: 8.83%
  • Return on Equity: 14.36%
  • Return on Assets: 2.84%
Misc:
  • Average Volume: 2.53 million shs.
 

Frequently Asked Questions for AstraZeneca plc (LON:AZN)

What is AstraZeneca plc's stock symbol?

AstraZeneca plc trades on the London Stock Exchange (LON) under the ticker symbol "AZN."

How often does AstraZeneca plc pay dividends? What is the dividend yield for AstraZeneca plc?

AstraZeneca plc declared a dividend on Thursday, July 27th. Shareholders of record on Thursday, August 10th will be paid a dividend of GBX 68.90 per share on Monday, September 11th. This represents a yield of 1.35%. The ex-dividend date is Thursday, August 10th. The official announcement can be seen at this link. View AstraZeneca plc's Dividend History.

Where is AstraZeneca plc's stock going? Where will AstraZeneca plc's stock price be in 2017?

21 brokers have issued 1 year price targets for AstraZeneca plc's stock. Their forecasts range from GBX 3,800 to GBX 6,500. On average, they expect AstraZeneca plc's stock price to reach GBX 5,202.29 in the next twelve months. View Analyst Ratings for AstraZeneca plc.

Who are some of AstraZeneca plc's key competitors?

Who are AstraZeneca plc's key executives?

AstraZeneca plc's management team includes the folowing people:

  • Pascal Soriot, Executive Director and Chief Executive Officer
  • Marc Dunoyer, Executive Director, Chief Financial Officer
  • Fiona Cicconi, Executive Vice-President, Human Resources
  • Sean Bohen M.D., Ph.D., Chief Medical Officer, Executive Vice President - Global Medicines Development
  • Pam P. Cheng, Executive Vice President - Operations and Information Technology
  • Ruud Dobber, Executive Vice President, North America
  • Bahija Jallal Ph.D., Executive Vice President, MedImmune
  • Mark Mallon, Executive Vice President, Global Product and Portfolio Strategy, Global Medical Affairs & Corporate Affairs Executive Vice-President, International West
  • Menelas Pangalos, Executive Vice President - IMED Biotech Unit and Global Business Development
  • Leon Wang, Executive Vice President - Asia Pacific

How do I buy AstraZeneca plc stock?

Shares of AstraZeneca plc and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is AstraZeneca plc's stock price today?

One share of AstraZeneca plc stock can currently be purchased for approximately GBX 5,166.


MarketBeat Community Rating for AstraZeneca plc (LON AZN)
Community Ranking:  2.1 out of 5 (star star)
Outperform Votes:  901 (Vote Outperform)
Underperform Votes:  1,246 (Vote Underperform)
Total Votes:  2,147
MarketBeat's community ratings are surveys of what our community members think about AstraZeneca plc and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for AstraZeneca plc (LON:AZN) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 3 Sell Ratings, 6 Hold Ratings, 12 Buy Ratings
Consensus Rating:Hold (Score: 2.43)
Consensus Price Target: GBX 5,202.29
Consensus Price Target History for AstraZeneca plc (LON:AZN)
Price Target History for AstraZeneca plc (LON:AZN)
Analysts' Ratings History for AstraZeneca plc (LON:AZN)
Show:
DateFirmActionRatingPrice TargetDetails
10/17/2017Shore CapitalReiterated RatingHoldView Rating Details
10/17/2017Goldman Sachs Group, Inc. (The)Reiterated RatingSellGBX 3,800View Rating Details
10/16/2017Credit Suisse GroupUpgradeNeutral -> OutperformGBX 4,800 -> GBX 5,800View Rating Details
10/16/2017Jefferies Group LLCBoost Price TargetHoldGBX 4,900 -> GBX 5,100View Rating Details
10/11/2017Deutsche Bank AGReiterated RatingBuyGBX 5,600View Rating Details
10/9/2017HSBC Holdings plcBoost Price TargetReduceGBX 4,100 -> GBX 4,150View Rating Details
10/5/2017Barclays PLCReiterated RatingOverweightGBX 6,300View Rating Details
9/25/2017BNP ParibasSet Price TargetBuyGBX 5,800View Rating Details
9/25/2017Sanford C. BernsteinSet Price TargetBuyGBX 5,780View Rating Details
9/21/2017Societe GeneraleReiterated RatingBuyView Rating Details
9/19/2017Berenberg BankSet Price TargetBuyGBX 5,800View Rating Details
9/14/2017Liberum CapitalDowngradeBuy -> HoldGBX 4,800 -> GBX 5,000View Rating Details
9/14/2017J P Morgan Chase & CoReiterated RatingNeutralGBX 4,500View Rating Details
9/13/2017Citigroup Inc.Set Price TargetBuyGBX 6,000View Rating Details
9/11/2017Kepler Capital MarketsReiterated RatingBuyGBX 5,200View Rating Details
9/11/2017Bryan, Garnier & CoUpgradeBuyGBX 4,700 -> GBX 5,380View Rating Details
9/6/2017NatixisUpgradeNeutral -> BuyGBX 5,000 -> GBX 5,738View Rating Details
8/9/2017InvestecUpgradeHold -> BuyGBX 5,000 -> GBX 4,900View Rating Details
7/28/2017Morgan StanleyDowngradeEqual WeightGBX 5,600 -> GBX 4,700View Rating Details
7/28/2017Beaufort SecuritiesDowngradeSellGBX 3,900View Rating Details
7/27/2017S&P GlobalSet Price TargetNeutralGBX 4,500View Rating Details
6/24/2016Independent Research GmbHSet Price TargetSellGBX 3,650View Rating Details
5/10/2016Oddo SecuritiesReiterated RatingBuyGBX 5,400View Rating Details
5/5/2016Charles StanleyUpgradeStrong-BuyView Rating Details
3/23/2016NomuraLower Price TargetHoldGBX 4,880 -> GBX 4,350View Rating Details
2/12/2016Baader BankReiterated RatingHoldGBX 4,400View Rating Details
2/9/2016AlphaValueUpgradeBuyGBX 4,640View Rating Details
2/4/2016S&P Equity ResearchSet Price TargetNeutralGBX 4,500View Rating Details
2/2/2016HandelsbankenReiterated RatingAccumulateGBX 5,220.30View Rating Details
1/28/2016Pareto SecuritiesReiterated RatingSellGBX 3,855.35View Rating Details
1/27/2016SwedbankReiterated RatingBuyGBX 5,115.47View Rating Details
1/13/2016Nordea Equity ResearchReiterated RatingHoldGBX 4,698.35View Rating Details
(Data available from 10/18/2015 forward)

Earnings

Earnings History for AstraZeneca plc (LON:AZN)
No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for AstraZeneca plc (LON:AZN)
Current Year EPS Consensus Estimate: $3.76 EPS

Dividends

Dividend History by Quarter for AstraZeneca plc (LON AZN)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
7/27/2017GBX 68.901.35%8/10/20178/10/20179/11/2017
2/2/2017GBX 150.203.52%2/16/20172/16/20173/20/2017
7/28/2016GBX 68.701.37%8/11/20168/11/20169/12/2016
2/4/2016GBX 1313.16%2/18/20162/18/20163/21/2016
7/30/2015GBX 57.501.33%8/13/20158/13/20159/14/2015
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading and Institutional Ownership History for AstraZeneca plc (LON:AZN)
Insider Trades by Quarter for AstraZeneca plc (LON:AZN)
Insider Trades by Quarter for AstraZeneca plc (LON:AZN)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
7/27/2017Nazneen RahmanInsiderBuy39GBX 4,370£1,704.30
10/27/2015Courtois,Jean-PhilippeInsiderBuy900GBX 4,423£39,807
8/28/2015Soriot,PascalInsiderBuy76,300GBX 3,960£3,021,480
5/7/2015Marc DunoyerInsiderBuy10,000GBX 4,397£439,700
4/30/2015Ann CairnsInsiderBuy1,100GBX 4,455£49,005
4/29/2015Shriti VaderaInsiderBuy3,500GBX 4,563£159,705
4/28/2015Graham ChipchaseInsiderBuy1,100GBX 4,606£50,666
4/27/2015Bruce BurlingtonInsiderBuy600GBX 4,662£27,972
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for AstraZeneca plc (LON:AZN)
Latest Headlines for AstraZeneca plc (LON:AZN)
Source:
DateHeadline
americanbankingnews.com logoAstraZeneca plc's (AZN) "Hold" Rating Reiterated at Shore Capital
www.americanbankingnews.com - October 17 at 6:30 AM
reuters.com logoNovo Nordisk diabetes drug works; no heart risk-FDA review
www.reuters.com - October 16 at 10:05 PM
americanbankingnews.com logoAstraZeneca plc (AZN) PT Set at GBX 5,800 by Credit Suisse Group
www.americanbankingnews.com - October 16 at 7:20 AM
finance.yahoo.com logoDrug Companies Fear Brexit Will Hit Medicine Trade
finance.yahoo.com - October 16 at 2:04 AM
finance.yahoo.com logo5 Large-Cap Drug Stocks Well Poised to Beat on Q3 Earnings - Yahoo Finance
finance.yahoo.com - October 15 at 9:04 PM
investorplace.com logoHold Rating for AstraZeneca (AZN) Retained - Investorplace.com (blog)
investorplace.com - October 15 at 2:06 AM
americanbankingnews.com logoAstraZeneca plc (AZN) Given a GBX 4,550 Price Target at UBS AG
www.americanbankingnews.com - October 9 at 10:06 AM
americanbankingnews.com logoAstraZeneca plc's (AZN) "Overweight" Rating Reiterated at Barclays PLC
www.americanbankingnews.com - October 8 at 11:16 AM
americanbankingnews.com logoAstraZeneca plc (AZN) Rating Reiterated by Deutsche Bank AG
www.americanbankingnews.com - October 8 at 10:02 AM
finance.yahoo.com logoFTSE scales two-month peak
finance.yahoo.com - October 6 at 8:38 AM
finance.yahoo.com logoDrug industry gives up legal battle over new UK cost curbs
finance.yahoo.com - October 5 at 2:23 PM
americanbankingnews.com logoAstraZeneca plc (AZN) Given Average Rating of "Hold" by Analysts
www.americanbankingnews.com - October 4 at 6:52 AM
nasdaq.com logoAstraZeneca's Bevespi Improves Lung Function in Phase III Study - Nasdaq
www.nasdaq.com - September 28 at 12:45 AM
zacks.com logoAstraZeneca's Bevespi Improves Lung Function in Phase III Study
www.zacks.com - September 27 at 7:44 PM
americanbankingnews.com logoAstraZeneca plc (AZN) Given a GBX 5,800 Price Target at BNP Paribas
www.americanbankingnews.com - September 25 at 4:44 PM
americanbankingnews.com logoBerenberg Bank Analysts Give AstraZeneca plc (AZN) a GBX 5,800 Price Target
www.americanbankingnews.com - September 24 at 2:08 PM
americanbankingnews.com logoSociete Generale Reiterates "Buy" Rating for AstraZeneca plc (AZN)
www.americanbankingnews.com - September 23 at 5:22 PM
msn.com logoWhy I’d ditch this defensive dividend stock to buy AstraZeneca plc
www.msn.com - September 18 at 4:43 PM
americanbankingnews.com logoAstraZeneca plc (AZN) PT Set at GBX 4,900 by Jefferies Group LLC
www.americanbankingnews.com - September 18 at 6:30 AM
americanbankingnews.com logoAstraZeneca plc (AZN) Given a GBX 6,000 Price Target by Citigroup Inc. Analysts
www.americanbankingnews.com - September 17 at 7:38 PM
americanbankingnews.com logoAstraZeneca plc (AZN) Stock Rating Reaffirmed by J P Morgan Chase & Co
www.americanbankingnews.com - September 17 at 1:32 PM
americanbankingnews.com logoLiberum Capital Downgrades AstraZeneca plc (AZN) to Hold
www.americanbankingnews.com - September 17 at 11:38 AM
americanbankingnews.com logoBarclays PLC Analysts Give AstraZeneca plc (AZN) a GBX 6,300 Price Target
www.americanbankingnews.com - September 13 at 6:04 PM
prnewswire.com logoBreakfast Technical Briefing on Drug Makers Stocks -- AbbVie, AstraZeneca ...
www.prnewswire.com - September 13 at 5:28 PM
bizjournals.com logoBreakfast Technical Briefing on Drug Makers Stocks -- AbbVie, AstraZeneca, Bristol Myers Squibb, and Johnson & Johnson
www.bizjournals.com - September 13 at 5:28 PM
finance.yahoo.com logoAstraZeneca's Asthma Candidate Shows Promising Results
finance.yahoo.com - September 12 at 4:32 PM
americanbankingnews.com logoAstraZeneca plc (AZN) Given a GBX 4,550 Price Target by UBS AG Analysts
www.americanbankingnews.com - September 12 at 12:40 AM
americanbankingnews.com logoAstraZeneca plc (AZN) Given a GBX 5,300 Price Target at BNP Paribas
www.americanbankingnews.com - September 12 at 12:08 AM
thestreet.com logoAstraZeneca Spikes After Lung Cancer Treat Study Shows 'Encouraging' Results
www.thestreet.com - September 11 at 4:53 PM
bloomberg.com logoAstraZeneca Wins in Cancer by Going Its Own Way
www.bloomberg.com - September 11 at 4:53 PM
seekingalpha.com logoAstraZeneca (AZN) Presents At European Society For Medical Oncology Annual Congress - Slideshow
seekingalpha.com - September 11 at 4:52 PM
americanbankingnews.com logoAstraZeneca plc's (AZN) Buy Rating Reiterated at Berenberg Bank
www.americanbankingnews.com - September 11 at 9:30 AM
americanbankingnews.com logoAstraZeneca plc (AZN) Given "Neutral" Rating at J P Morgan Chase & Co
www.americanbankingnews.com - September 9 at 8:18 PM
finance.yahoo.com logoAstraZeneca CEO, worried by Brexit, not signing UK government letter
finance.yahoo.com - September 9 at 4:03 PM
finance.yahoo.com logoAstraZeneca CEO, worried by Brexit, not signing UK government letter
finance.yahoo.com - September 9 at 4:03 PM
americanbankingnews.com logoAstraZeneca plc (AZN) Receives Average Recommendation of "Hold" from Brokerages
www.americanbankingnews.com - September 9 at 6:26 AM
finance.yahoo.com logoAstraZeneca rebuilds cancer drug hopes with new lung data
finance.yahoo.com - September 8 at 9:43 PM
finance.yahoo.com logo[$$] AstraZeneca looks for boost from positive trials
finance.yahoo.com - September 8 at 9:43 PM
finance.yahoo.com logoAstraZeneca shares tick higher on lung cancer drug study results
finance.yahoo.com - September 8 at 9:43 PM
finance.yahoo.com logoMerck's immunotherapy, chemo mix shows extended lung cancer gains
finance.yahoo.com - September 7 at 9:26 PM
rttnews.com logoAstraZeneca Announces Results From PATHWAY Phase IIb Trial Of Tezepelumab
www.rttnews.com - September 7 at 4:23 PM
zacks.com logoAstraZeneca's COPD Candidate Duaklir Reports Positive Data
www.zacks.com - September 7 at 4:23 PM
americanbankingnews.com logoCitigroup Inc. Reiterates GBX 6,000 Price Target for AstraZeneca plc (AZN)
www.americanbankingnews.com - September 7 at 7:18 AM
americanbankingnews.com logoAstraZeneca plc (AZN) Upgraded by Natixis to "Buy"
www.americanbankingnews.com - September 6 at 7:20 AM
americanbankingnews.com logoAstraZeneca plc (AZN) Receives "Neutral" Rating from J P Morgan Chase & Co
www.americanbankingnews.com - September 5 at 12:32 AM
finance.yahoo.com logoNikkei climbs to 2-week highs as U.S. data bolsters dollar-yen
finance.yahoo.com - August 31 at 3:38 AM
americanbankingnews.com logoJefferies Group LLC Lowers AstraZeneca plc (AZN) Price Target to GBX 4,350
www.americanbankingnews.com - August 27 at 8:32 PM
finance.yahoo.com logo[$$] AstraZeneca reverses stance with plan for UK investment
finance.yahoo.com - August 27 at 3:58 PM
americanbankingnews.com logoAstraZeneca plc's (AZN) Buy Rating Reaffirmed at Liberum Capital
www.americanbankingnews.com - August 21 at 7:14 PM
americanbankingnews.com logoAstraZeneca plc (AZN) Earns "Hold" Rating from Shore Capital
www.americanbankingnews.com - August 20 at 12:50 AM

Social

Social activity is not available for this stock.

Chart

AstraZeneca plc (AZN) Chart for Wednesday, October, 18, 2017

This page was last updated on 10/18/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.